Options for Patients with Polycythemia Vera

Ruben A. Mesa, MD

Video Categories: Polycythemia Vera

Hear Dr. Mesa discuss options available for individual patients who have failed hydroxyurea polycythemia vera.

Supported through funding from Incyte
December 18, 2018

Reimbursement Challenges and Solutions with Molecular Biomarker Testing

Drs. Geoffrey Oxnard and Lauren Ritterhouse consider the current landscape of reimbursement for molecular biomarker testing, the need to run FDA-approved tests, and the role of CMS and local Medicare providers in testing reimbursement.

November 24, 2014

Foundation Medicine on a Molecular Level

Dr. Gary Palmer explains how Foundation Medicine is working to improve cancer therapies and personalized medicine on a molecular level.